Joel Lewis Galectin Therapeutics Inc (GALT) insider trading activity

GALT Quotes by TradingView

Joel Lewis is President and CEO of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 832,592 shares of GALT, which is worth approximately $4.58 Million. The most recent transaction as insider was on Dec 15, 2020, when has been sold 6,614 shares (Common Stock) at a price of $2.52 per share, resulting in proceeds of $16,667. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 833K
0% 3M change
7.18% 12M change
Total Value Held $4.58 Million

JOEL LEWIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2020
BUY
Grant, award, or other acquisition
$16,667 $2.52 p/Share
6,614 Added 4.22%
149,971 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$16,666 $2.6 p/Share
6,410 Added 4.28%
143,357 Common Stock
Nov 13 2020
BUY
Grant, award, or other acquisition
$16,668 $2.75 p/Share
6,061 Added 4.24%
136,947 Common Stock
Oct 30 2020
BUY
Grant, award, or other acquisition
$16,667 $2.54 p/Share
6,562 Added 4.77%
130,886 Common Stock
Oct 15 2020
BUY
Grant, award, or other acquisition
$16,666 $2.87 p/Share
5,807 Added 4.46%
124,324 Common Stock
Sep 30 2020
BUY
Grant, award, or other acquisition
$16,666 $2.67 p/Share
6,242 Added 5.0%
118,517 Common Stock
JL

Joel Lewis

President and CEO
Norcross, GA

Track Institutional and Insider Activities on GALT

Follow GALECTIN THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

News

Receive news related to GALECTIN THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GALT